1-3 of 3
Martina Sanlorenzo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells

Ramona Rotolo, Valeria Leuci, Chiara Donini, Federica Galvagno, Annamaria Massa, Maria Chiara De Santis, Serena Peirone, Giovanni Medico, Martina Sanlorenzo, Igor Vujic, Loretta Gammaitoni, Marco Basiricò, Luisella Righi, Chiara Riganti, Iris Chiara Salaroglio, Francesca Napoli, Fabrizio Tabbò, Annapaola Mariniello, Elisa Vigna, Chiara Modica, Lorenzo D’Ambrosio, Giovanni Grignani, Riccardo Taulli, Emilio Hirsch, Matteo Cereda, Massimo Aglietta, Giorgio Vittorio Scagliotti, Silvia Novello, Paolo Bironzo, Dario Sangiolo
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (3): 621–634.
https://doi.org/10.1158/1078-0432.CCR-22-0761
Published: 01 February 2023
View article titled, Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1<sup>+</sup> Chemoresistant Lung Cancer Cells
Open the PDF for Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1<sup>+</sup> Chemoresistant Lung Cancer Cells in another window
Includes: Supplementary data
Journal Articles

BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody

Martina Sanlorenzo, Igor Vujic, Arianna Floris, Mauro Novelli, Loretta Gammaitoni, Lidia Giraudo, Marco Macagno, Valeria Leuci, Ramona Rotolo, Chiara Donini, Marco Basiricò, Pietro Quaglino, Maria Teresa Fierro, Silvia Giordano, Maria Sibilia, Fabrizio Carnevale-Schianca, Massimo Aglietta, Dario Sangiolo
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (14): 3377–3385.
https://doi.org/10.1158/1078-0432.CCR-17-1914
Published: 15 July 2018
View article titled, BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody
Open the PDF for BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody in another window
Includes: Supplementary data
Journal Articles

Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells

Loretta Gammaitoni, Lidia Giraudo, Marco Macagno, Valeria Leuci, Giulia Mesiano, Ramona Rotolo, Francesco Sassi, Martina Sanlorenzo, Alessandro Zaccagna, Alberto Pisacane, Rebecca Senetta, Michela Cangemi, Giulia Cattaneo, Valentina Martin, Valentina Coha, Susanna Gallo, Ymera Pignochino, Anna Sapino, Giovanni Grignani, Fabrizio Carnevale-Schianca, Massimo Aglietta, Dario Sangiolo
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (9): 2277–2288.
https://doi.org/10.1158/1078-0432.CCR-16-1524
Published: 30 April 2017
View article titled, Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells
Open the PDF for Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells in another window
Includes: Supplementary data